SCHEMBL1581964

SCHEMBL1581964

CCOc1ccc(-c2ccc(C3(O)CCN(C(=O)O)CC3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
TET3 O43151 2/20 0.52
FBXL19 Q6PCT2 2/20 0.52
TET1 Q8NFU7 2/20 0.52
KDM2B Q8NHM5 2/20 0.52
CXXC4 Q9H2H0 2/20 0.52
KDM2A Q9Y2K7 2/20 0.52
CXXC5 Q7LFL8 1/20 0.52
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.45
KDM4E B2RXH2 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HSD17B10 Q99714 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 1/20 0.44
CCR1 P32246 1/20 0.43
ADORA2A P29274 2/20 0.42
ADORA2B P29275 2/20 0.42
GAA P10253 1/20 0.42
FKBP1A P62942 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1581919 0.85 OPRM1 (0.56) KMT2ATET3FBXL19TET1KDM2B
SCHEMBL15020023 0.82 DRD2 (0.53) KMT2AALDH1A1HPGDMEN1LMNA
SCHEMBL5452097 0.81 GAA (0.46) KMT2ATET3FBXL19TET1KDM2B
SCHEMBL16874836 0.80 OPRM1 (0.59) KMT2ATET3FBXL19TET1KDM2B
SCHEMBL1581749 0.80 OPRM1 (0.51) KMT2AALDH1A1MEN1SMN1; SMN2
SCHEMBL5468647 0.78 MAPT (0.47) KMT2ATET3FBXL19TET1KDM2B
SCHEMBL1581807 0.78 OPRL1 (0.58) KMT2AALDH1A1HPGDHSD17B10MEN1
SCHEMBL1581499 0.77 MEN1 (0.58) KMT2AALDH1A1KDM4EMEN1CCR1
SCHEMBL1581427 0.77 OPRM1 (0.51) CCR1SMN1; SMN2
SCHEMBL5238376 0.77 MAPT (0.54) KMT2AALDH1A1HPGDKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720872-B1 ARYL AND HETEROARYL-PIPERIDINECARBOXYLATE DERIVATIVES, THE PREPARATION AND THE USE THEREOF IN THE FORM OF FAAH ENZYME INHIBITORS SANOFI AVENTIS (FR) 2011-04-20 EP disclosed